Answers are grounded in this paper and cite their sources.
Decentralized clinical trials have gained in popularity over the last years due to their advantages related to broadening recruitment strategies and resource saving possibilities. As more clinical trials adopt decentralized strategies, it is essential to share the knowledge about both successful and unsuccessful efforts in the research community. In the present commentary, we explore potential reasons that led to early termination of a decentralized clinical trial in Oncology.
No takes yet. Share an insight, caveat, or question.
Valachis et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: